How to Buy Veracyte Stock
Veracyte Inc
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Genomic Sequencing Classifier and Percepta Nasal Swab Test for lung cancer diagnosis; Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis; and Immunoscore Colon Cancer test for colon cancer diagnosis.
Veracyte stock last closed at $19.90, up 0.35% from the previous day, and has decreased 14.26% in one year. It has overperformed other stocks in the Biotechnology industry by 0.09 percentage points. Veracyte stock is currently +6.93% from its 52-week low of $18.61, and -34.8% from its 52-week high of $30.52.
As of Apr 24, 2024, there are 75.07M VCYT shares outstanding. The market cap of VCYT is $1.49B. In the past 24 hours, 497,400 VCYT shares were traded.
How to Buy Veracyte Stock
Not sure how to invest in Veracyte stock? Here's how.
- Choose where to buy Veracyte stock: You need to pick a stock brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you figure out where to buy Veracyte stock.
- Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit money your brokerage account: Select your payment method and add your information.
- Research Veracyte stock: The Veracyte ticker symbol is VCYT. Is Veracyte stock a good investment? Should you buy shares of VCYT? How do VCYT's underlying business fundamentals look? Do top analysts think Veracyte is a good buy? Why has VCYT's stock price moved recently? (Hint: Our stock research website can help you figure out if VCYT is a good stock to buy).
- Place your VCYT buy order: Decide if you will purchase VCYT shares at the current market price or use a limit order to purchase VCYT stock at a particular price.
- Keep an eye on your VCYT position: Create a watchlist to get the latest news on your new investment in Veracyte stock.
Step 1: Choose where to buy Veracyte stock
You will need a brokerage account in order to access the NASDAQ market and buy VCYT stock.
Our favorite brokerage: eToro
In our opinion, eToro is the best brokerage. eToro gives you:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world markets: From Technology to Financial Services, New York to London — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by opening an account with eToro now.
Open eToro AccountStep 2: Create a brokerage account
Now that you've chosen your brokerage, it's time to fill out some personal information so you can invest in VCYT today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to start your new brokerage account.
- Send your info by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you've finished signing up on the best stock trading app, you need to deposit funds:
Watch the video below if you need help transferring money into your new brokerage account.
Step 4: Research Veracyte stock
After you have figured out the best place to buy Veracyte stock, it's critical to research their stock prior to investing, so you truly wrap your head around the risk and opportunity.
Veracyte shares at a glance
Fundamentals of Veracyte
WallStreetZen was designed to help average investors perform more accurate fundamental analysis quickly.
You can view all of the due diligence checks on VCYT's stock page.
How is VCYT stock valued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge VCYT's intrinsic value.
Using relative valuations ratios:
- VCYT could be undervalued based on its P/B ratio of 1.43x, relative to Biotechnology industry P/B ratio of 5.86x
You can access additional valuation research on VCYT's stock here.
VCYT Financial Overview
Signs that VCYT is financially healthy:
- Total VCYT debt is lower than 5 years ago, relative to shareholder equity.
- VCYT has a low debt to equity ratio of 0.07.
- There are more short-term assets than short-term liabilities on the VCYT balance sheet.
- VCYT's operating cash flow of $44.22M allows it to safely service it's debt of $12.63M.
- There are more short-term assets than long-term liabilities on the VCYT balance sheet.
Signs that VCYT is not financially healthy:
- VCYT earnings of -$76.61M is not sufficient to cover its interest payments.
- VCYT profit margin has gone down from -12.3% to -20.6% in the past year.
Is it a good time to buy Veracyte stock, according to analysts?
Out of 3 Wall Street analysts who give ratings on VCYT, the consensus analyst rating on Veracyte is a Hold
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dig deeper into what analysts are saying on the Veracyte stock forecast page.
VCYT Trading Indicators
VCYT Growth Metrics
Last year, VCYT revenue was $361.05M. In the last 5 year, VCYT's revenue has gone up by 31.45% per year. This was faster than the Biotechnology industry average of 28.91%.
You can analyze VCYT's earnings and revenue performance here.
Are VCYT insiders buying or selling the stock?
In the past year, executives and large shareholders at VCYT have sold more shares than they have bought.
Karin Eastham, Director of VCYT, was the latest VCYT insider to sell. They sold $216,530.00 worth of VCYT shares on Apr 1, 2024.
Dig into more about who owns VCYT stock here.
Does VCYT provide a stable income stream?
No, Veracyte doesn't provide an income stream by paying out dividends.
What others are saying about VCYT
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Place your VCYT buy order
You have two primary options:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are mostly fine for most investors. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at an exact dollar amount limit, place a limit order.
Click the Open button and eToro will place the order.
If you want additional assistance investing in stocks on eToro, click the helpful video below:
Step 6: Keep an eye on your VCYT position
Now that you own some VCYT shares, you'll want to keep up with your new investment.
Create a watchlist to see the latest developments about your VCYT stock.
VCYT Feed
How to Buy Stock in Veracyte
To summarize, here are the 6 steps to buy stock in Veracyte:
- Choose where to buy Veracyte stock
- Create a brokerage account
- Deposit money your brokerage account
- Research Veracyte stock
- Place your VCYT buy order
- Keep an eye on your VCYT position
If you need a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get the latest news on your investment in Veracyte, click the button below.
Other Articles You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.